- $1.25bn
- $1.29bn
- $1.53bn
- 91
- 55
- 80
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,347 | 1,398 | 1,580 | 1,711 | 1,532 |
Cost of Revenue | |||||
Gross Profit | 395 | 396 | 457 | 501 | 427 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1,273 | 1,317 | 1,473 | 1,594 | 1,445 |
Operating Profit | 74.8 | 80.3 | 107 | 117 | 87.1 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 71.4 | 75.2 | 99.3 | 102 | 85.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 54.6 | 56 | 75.2 | 75.4 | 61.1 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 131 | 56 | 75.2 | 75.4 | 61.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 131 | 56 | 75.2 | 75.4 | 61.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.3 | 2.62 | 3.66 | 3.68 | 3.21 |
Dividends per Share |